Sands Capital's position in Amphenol Corp. is currently worth $106M. That's 0.31% of their equity portfolio (47th largest holding). The stake costed the investor $64.4M, netting the investor a gain of 65% so far.
TimesSquare Capital Management, an equity investment management company, released its ¡°U.S. Mid Cap Growth Strategy¡± fourth-quarter investor letter. A copy o...
https://www.investing.com/news/pro/amphenol-pt-raised-to-80-at-rbc-capital-432SI-2923438
RBC Capital Stick to Their Hold Rating for Amphenol Corp
GAINERS: MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 42.86% at $0.02 Australis Capital (OTCQB: AUSAF ) shares closed up 42.68% at $0.12 Zelira Therap...